The Oncology Institute (NASDAQ: TOI ) is a company bringing together cancer care practices around the United States. Their main focus is to reduce costs related to oncological treatments and cancer patient management. Their services encompass patient services toAt ELAM1, we empower financial professionals and investors with the scientific and clinical expertise required to navigate the complexities of the healthcare sector. By bridging the gap between cutting-edge science and financial strategy, we help our ...

Core Insights - The Oncology Institute, Inc. (TOI) is one of the largest value-based oncology groups in the United States, focusing on specialized cancer care [1][2] - TOI will participate in B. Riley's 25th Annual Institutional Investor Conference on May 21, 2025, with key executives attending [1] Company Overview - Founded in 2007, TOI provides value-based cancer care to over 1.8 million patients, including services like clinical trials and transfusions [2] - The organization employs over 120 clinicians and has more than 700 staff across 70 clinic locations, aiming to improve oncology care [2]